KCTD13 Antikörper (C-Term)

Produktnummer ABIN1536895

Produktdetails anti-KCTD13 Antikörper

Target: KCTD13 (Potassium Channel Tetramerisation Domain Containing 13 (KCTD13))

Bindungsspezifität: AA 229-258, C-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser KCTD13 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Homologie: B, Zf, M, C, Rat, X

Aufreinigung: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogen: This KCTD13 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 229-258 amino acids from the C-terminal region of human KCTD13.

Klon: RB37916

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: WB: 1:1000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: KCTD13 Antibody (C-term) can be refrigerated at 2-8 °C for up to 6 months. For long term storage, keep at -20 °C.

Haltbarkeit: 6 months

Details zu KCTD13

Target: KCTD13 (Potassium Channel Tetramerisation Domain Containing 13 (KCTD13))

Andere Bezeichnung: KCTD13 (KCTD13 Produkte)

Hintergrund: Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex involved in regulation of cytoskeleton structure. The BCR(BACURD1) E3 ubiquitin ligase complex mediates the ubiquitination of RHOA, leading to its degradation by the proteasome, thereby regulating the actin cytoskeleton and cell migration.

Molekulargewicht: 36357

Gen-ID: 253980

NCBI Accession: NP_849194

UniProt: Q8WZ19